Sort
23,748 grants matching “melanoma”
Why red-haired individuals are so prone to developing melanoma
$374,464Rutao Cui · Boston University Medical Campus · R01 · FY2015 · CA
The Significance of MARCO Expression by Tumor-Pulsed Dendritic Cells
$374,438James J Mule · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2009 · CA
CD8+ T Cell-Mediated Immunotherapy of Autochthonous SV40 T Antigen-Induced Tumors
$374,436Todd D Schell · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2011 · CA
GMPS-GMPR axis melanoma progression and therapy
$374,421Mikhail Nikiforov · Wake Forest University Health Sciences · R01 · FY2021 · CA
Developing Tumor-specific PROTACs
$374,408Craig M Crews · Yale University · R01 · FY2022 · CA
Statistical Methods for Population Genomics and "Next-gen" Sequencing Data
$374,395Paul A Scheet · University Of Tx Md Anderson Can Ctr · R01 · FY2015 · HG
CD8+ T Cell-Mediated Immunotherapy of Autochthonous SV40 T Antigen-Induced Tumors
$374,388Todd D Schell · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2012 · CA
Therapeutic Mechanism of CD47 Blockade in Suppressing Melanoma Metastasis
$374,372Alexander D Boiko · Cedars-Sinai Medical Center · R01 · FY2023 · CA
Regulation of interferon signaling in melanoma by the cohesin complex protein STAG2 via 3D genome organization
$374,372Bin Zheng · Cedars-Sinai Medical Center · R01 · FY2023 · CA
Use of focused ultrasound to increase melanoma immunogenicity and inhibit tumor-induced T cell tolerance
$374,372Fernando Macian · Albert Einstein College Of Medicine · R01 · FY2022 · CA
THERAPEUTIC STUDIES--DENDRITIC CELL BASED CANCER VACCINE
$374,333H. Lee Moffitt Cancer Ctr &Res Inst · R01 · FY2004 · CA
MAINLINE HEALTH CCOP
$374,190Lankenau Institute For Medical Research · U10 · FY2003 · CA
Melanoma immunotherapy targeting sentinel lymph nodes
$374,018Susan Napier Thomas · Georgia Institute Of Technology · R01 · FY2016 · CA
Antigen-independent prediction and biomarker identification of cancer-specific T cells
$374,006Bo Li · Ut Southwestern Medical Center · R01 · FY2020 · CA
Tailored Intervention for Melanoma Patients' Families
$373,977Sharon L Manne · Fox Chase Cancer Center · R01 · FY2008 · CA
Adoptive T cell Therapy of Melanoma Targeting NY-ESO-1
$373,963Cassian Yee · Fred Hutchinson Cancer Research Center · R01 · FY2012 · CA
Cell Surface Lectins and Intercellular Adhesion
$373,936Steven D Rosen · University Of California, San Francisco · R01 · FY2007 · GM
Mechanisms of PDT in Patients
$373,852Nathalie Zeitouni · Roswell Park Cancer Institute Corp · P01 · FY2009 · CA
Nuclear receptors: action, functions, and roles in disease
$373,851Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES
Microfluidic Precision Engineered Artificial Antigen Presenting Cells for Cancer Immunotherapy
$373,718Abraham P Lee · University Of California-Irvine · R33 · FY2023 · CA
Development and Mechanistic Studies of an Engineered Human Enzyme to Abrogate Immune Suppression due to Elevated Methylthioadenosine (MTA) by MTAP null/low Tumors
$373,697Everett Stone · University Of Texas At Austin · R01 · FY2019 · CA
Investigating 53BP1 'dephosphorylation' as a critical determinant of PARP
$373,682Dipanjan Chowdhury · Dana-Farber Cancer Inst · R01 · FY2019 · CA
Mouse Resource Core
$373,634Edward A Clark · University Of Washington · U19 · FY2016 · AI
Eradication of Escaped Variant Tumor Cells for Cancer Immunotherapy
$373,617Yong Lu · Wake Forest University Health Sciences · R01 · FY2021 · CA
An S-Plus Functional Data Analysis Module
$373,603Insightful Corporation · R44 · FY2003 · CA